Bcl2l11 | Rat | (-)-demecolcine | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Demecolcine results in increased expression of BCL2L11 mRNA | CTD | PMID:23649840 |
Bcl2l11 | Rat | (S)-amphetamine | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [N-Methyl-3 more ... | CTD | PMID:23820845 |
Bcl2l11 | Rat | (S)-amphetamine | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Dextroamphetamine results in increased expression of BCL2L11 mRNA and Dextroamphetamine results in increased expression of BCL2L11 protein | CTD | PMID:23820845 |
Bcl2l11 | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | EXP | | 6480464 | o more ... | CTD | PMID:22937105 |
Bcl2l11 | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | decreases expression | EXP | | 6480464 | o and p'-DDT analog results in decreased expression of BCL2L11 mRNA | CTD | PMID:22937105 |
Bcl2l11 | Rat | 1,1-dichloroethene | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of BCL2L11 mRNA | CTD | PMID:26682919 |
Bcl2l11 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of BCL2L11 mRNA | CTD | PMID:22206623 |
Bcl2l11 | Rat | 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-4-piperidinol | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | dorsomorphin inhibits the reaction [Penfluridol results in increased expression of BCL2L11 mRNA] more ... | CTD | PMID:35530161 |
Bcl2l11 | Rat | 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-4-piperidinol | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Penfluridol results in increased expression of BCL2L11 mRNA and Penfluridol results in increased expression of BCL2L11 protein | CTD | PMID:35530161 |
Bcl2l11 | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of BCL2L11 mRNA | CTD | PMID:30723492 |
Bcl2l11 | Rat | 17beta-estradiol | affects expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Estradiol affects the expression of BCL2L11 mRNA | CTD | PMID:21826169 |
Bcl2l11 | Rat | 17beta-estradiol | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Estradiol results in increased expression of BCL2L11 mRNA | CTD | PMID:23373633 more ... |
Bcl2l11 | Rat | 1H-pyrazole | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | pyrazole results in increased expression of BCL2L11 mRNA | CTD | PMID:17945193 |
Bcl2l11 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:21851831 |
Bcl2l11 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:27589474 |
Bcl2l11 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BCL2L11 mRNA | CTD | PMID:19520675 and PMID:33387578 |
Bcl2l11 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of BCL2L11 mRNA | CTD | PMID:34747641 |
Bcl2l11 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BCL2L11 mRNA | CTD | PMID:15800033 more ... |
Bcl2l11 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of BCL2L11 mRNA | CTD | PMID:21570461 |
Bcl2l11 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:21851831 and PMID:25975270 |
Bcl2l11 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BCL2L11 mRNA | CTD | PMID:19770486 |
Bcl2l11 | Rat | 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | [Trinitrobenzenesulfonic Acid results in increased expression of MAPK9 protein] promotes the reaction [BCL2L11 protein binds to MAPK9 protein] more ... | CTD | PMID:22427801 |
Bcl2l11 | Rat | 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of BCL2L11 protein | CTD | PMID:22427801 |
Bcl2l11 | Rat | 2-butoxyethanol | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | n-butoxyethanol results in increased expression of BCL2L11 mRNA | CTD | PMID:19812364 |
Bcl2l11 | Rat | 2-methoxyethanol | increases expression | EXP | | 6480464 | methyl cellosolve results in increased expression of BCL2L11 mRNA | CTD | PMID:19643169 |
Bcl2l11 | Rat | 2-palmitoylglycerol | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of BCL2L11 mRNA | CTD | PMID:37199045 |
Bcl2l11 | Rat | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23196670 |
Bcl2l11 | Rat | 3,4-methylenedioxymethamphetamine | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [N-Methyl-3 more ... | CTD | PMID:23820845 |
Bcl2l11 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | N-Methyl-3 more ... | CTD | PMID:23820845 |
Bcl2l11 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L11 mRNA | CTD | PMID:28628672 |
Bcl2l11 | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Bcl2l11 (Mus musculus) | 6480464 | bisphenol S affects the methylation of BCL2L11 gene | CTD | PMID:31683443 |
Bcl2l11 | Rat | 4-hydroxynon-2-enal | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | 4-hydroxy-2-nonenal results in increased expression of BCL2L11 mRNA | CTD | PMID:19191707 |
Bcl2l11 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Fenretinide results in increased expression of BCL2L11 mRNA | CTD | PMID:28973697 |
Bcl2l11 | Rat | 4-nitrophenol | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | 4-nitrophenol results in increased expression of BCL2L11 mRNA | CTD | PMID:34673133 |
Bcl2l11 | Rat | 4-nonylphenol | increases expression | EXP | | 6480464 | 4-nonylphenol results in increased expression of BCL2L11 protein | CTD | PMID:26804764 |
Bcl2l11 | Rat | 4-phenylbutyric acid | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of BCL2L11 protein] | CTD | PMID:34214594 |
Bcl2l11 | Rat | 4-vinylcyclohexene dioxide | affects expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | 4-vinyl-1-cyclohexene dioxide affects the expression of BCL2L11 mRNA | CTD | PMID:20829426 |
Bcl2l11 | Rat | 5-aza-2'-deoxycytidine | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Decitabine results in increased expression of BCL2L11 mRNA and Decitabine results in increased expression of BCL2L11 protein | CTD | PMID:19403302 |
Bcl2l11 | Rat | 5-aza-2'-deoxycytidine | decreases methylation | ISO | BCL2L11 (Homo sapiens) | 6480464 | Decitabine results in decreased methylation of BCL2L11 promoter | CTD | PMID:19403302 |
Bcl2l11 | Rat | 5-fluorouracil | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | Fluorouracil affects the reaction [rebamipide results in decreased expression of BCL2L11 protein] and rebamipide inhibits the reaction [Fluorouracil results in increased expression of BCL2L11 protein] | CTD | PMID:29054700 |
Bcl2l11 | Rat | 5-fluorouracil | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Fluorouracil results in increased expression of BCL2L11 protein | CTD | PMID:29054700 |
Bcl2l11 | Rat | 7-ketocholesterol | affects localization | ISO | BCL2L11 (Homo sapiens) | 6480464 | 7-ketocholesterol affects the localization of BCL2L11 protein | CTD | PMID:15955068 |
Bcl2l11 | Rat | 8-(4-chlorophenylthio)-cAMP | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | 8-((4-chlorophenyl)thio)cyclic-3' more ... | CTD | PMID:14996839 |
Bcl2l11 | Rat | 8-(4-chlorophenylthio)-cAMP | increases response to substance | ISO | Bcl2l11 (Mus musculus) | 6480464 | BCL2L11 protein results in increased susceptibility to 8-((4-chlorophenyl)thio)cyclic-3' and 5'-AMP | CTD | PMID:14996839 |
Bcl2l11 | Rat | 8-(4-chlorophenylthio)-cAMP | increases response to substance | ISO | BCL2L11 (Homo sapiens) | 6480464 | BCL2L11 protein results in increased susceptibility to 8-((4-chlorophenyl)thio)cyclic-3' and 5'-AMP | CTD | PMID:14996839 |
Bcl2l11 | Rat | 8-(4-chlorophenylthio)-cAMP | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | 8-((4-chlorophenyl)thio)cyclic-3' and 5'-AMP results in increased expression of BCL2L11 protein | CTD | PMID:14996839 |
Bcl2l11 | Rat | 8-Br-cAMP | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of BCL2L11 protein | CTD | PMID:16709600 |
Bcl2l11 | Rat | 9,10-anthraquinone | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | 9 and 10-anthraquinone analog results in increased expression of BCL2L11 protein | CTD | PMID:26915975 |
Bcl2l11 | Rat | 9-cis-retinoic acid | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Alitretinoin results in increased expression of BCL2L11 protein | CTD | PMID:16340750 |
Bcl2l11 | Rat | 9-cis-retinoic acid | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | seocalcitol inhibits the reaction [Alitretinoin results in increased expression of BCL2L11 protein] | CTD | PMID:16340750 |
Bcl2l11 | Rat | ABT-737 | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [ABT-737 inhibits the reaction [BCL2L11 protein binds to BCL2 protein]] promotes the reaction [BCL2L11 protein results in increased activity of BAX protein] more ... | CTD | PMID:17097560 more ... |
Bcl2l11 | Rat | ABT-737 | increases response to substance | ISO | Bcl2l11 (Mus musculus) | 6480464 | BCL2L11 protein results in increased susceptibility to ABT-737 | CTD | PMID:20038611 |
Bcl2l11 | Rat | acetylsalicylic acid | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Aspirin results in increased expression of BCL2L11 mRNA | CTD | PMID:19936928 |
Bcl2l11 | Rat | acrolein | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BCL2L11 mRNA more ... | CTD | PMID:32699268 and PMID:32845096 |
Bcl2l11 | Rat | actinomycin D | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of BCL2L11 mRNA] | CTD | PMID:16166651 |
Bcl2l11 | Rat | aflatoxin B1 | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of BCL2L11 mRNA | CTD | PMID:19770486 |
Bcl2l11 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of BCL2L11 mRNA | CTD | PMID:25378103 and PMID:33354967 |
Bcl2l11 | Rat | aldehydo-D-glucose | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]] and resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] | CTD | PMID:25471227 |
Bcl2l11 | Rat | aldehydo-D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of BCL2L11 protein | CTD | PMID:25471227 |
Bcl2l11 | Rat | all-trans-retinoic acid | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of BCL2L11 protein | CTD | PMID:19176369 |
Bcl2l11 | Rat | all-trans-retinoic acid | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of BCL2L11 mRNA | CTD | PMID:33167477 |
Bcl2l11 | Rat | alpha-pinene | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BCL2L11 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of BCL2L11 mRNA | CTD | PMID:32699268 |
Bcl2l11 | Rat | amiodarone | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Amiodarone results in increased expression of BCL2L11 mRNA | CTD | PMID:19774075 |
Bcl2l11 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of BCL2L11 mRNA | CTD | PMID:16483693 |
Bcl2l11 | Rat | ammonium chloride | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Ammonium Chloride results in increased expression of BCL2L11 mRNA | CTD | PMID:31310755 |
Bcl2l11 | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | pyrazolanthrone inhibits the reaction [sodium arsenite results in increased expression of BCL2L11 protein] | CTD | PMID:16166651 |
Bcl2l11 | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [docetaxel results in increased degradation of BCL2L11 protein] more ... | CTD | PMID:17317842 more ... |
Bcl2l11 | Rat | antirheumatic drug | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of BCL2L11 mRNA | CTD | PMID:24449571 |
Bcl2l11 | Rat | Aroclor 1254 | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of BCL2L11 mRNA | CTD | PMID:25270620 |
Bcl2l11 | Rat | arsenous acid | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of BCL2L11 mRNA and Arsenic Trioxide results in increased expression of BCL2L11 protein | CTD | PMID:17203211 more ... |
Bcl2l11 | Rat | arsenous acid | affects expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Arsenic Trioxide affects the expression of BCL2L11 protein | CTD | PMID:36509116 |
Bcl2l11 | Rat | arsenous acid | increases degradation | ISO | BCL2L11 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased degradation of BCL2L11 protein | CTD | PMID:36509116 |
Bcl2l11 | Rat | arsenous acid | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased degradation of BCL2L11 protein] more ... | CTD | PMID:21655183 more ... |
Bcl2l11 | Rat | asbestos | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Asbestos results in decreased expression of BCL2L11 | CTD | PMID:27042963 |
Bcl2l11 | Rat | Azaspiracid | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | azaspiracid results in decreased expression of BCL2L11 mRNA | CTD | PMID:28939011 |
Bcl2l11 | Rat | azoxystrobin | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | azoxystrobin results in decreased expression of BCL2L11 mRNA | CTD | PMID:33512557 |
Bcl2l11 | Rat | belinostat | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | belinostat results in increased expression of BCL2L11 protein | CTD | PMID:18223231 |
Bcl2l11 | Rat | benzo[a]pyrene | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of BCL2L11 mRNA | CTD | PMID:15735009 |
Bcl2l11 | Rat | benzo[a]pyrene | increases methylation | ISO | BCL2L11 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of BCL2L11 3' UTR and Benzo(a)pyrene results in increased methylation of BCL2L11 5' UTR | CTD | PMID:27901495 |
Bcl2l11 | Rat | benzo[a]pyrene | affects methylation | ISO | BCL2L11 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of BCL2L11 promoter | CTD | PMID:27901495 |
Bcl2l11 | Rat | benzo[a]pyrene | decreases methylation | ISO | Bcl2l11 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased methylation of BCL2L11 3' UTR more ... | CTD | PMID:27901495 |
Bcl2l11 | Rat | benzo[a]pyrene | increases methylation | ISO | Bcl2l11 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of BCL2L11 gene | CTD | PMID:28476633 |
Bcl2l11 | Rat | benzo[a]pyrene | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of BCL2L11 mRNA | CTD | PMID:26238291 |
Bcl2l11 | Rat | benzo[a]pyrene | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of BCL2L11 mRNA | CTD | PMID:19770486 and PMID:21715664 |
Bcl2l11 | Rat | benzo[a]pyrene | decreases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of BCL2L11 mRNA | CTD | PMID:20713471 |
Bcl2l11 | Rat | benzo[b]fluoranthene | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of BCL2L11 protein | CTD | PMID:21392559 |
Bcl2l11 | Rat | berberine | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Berberine co-treated with Niacinamide] results in increased expression of BCL2L11 mRNA | CTD | PMID:26712469 |
Bcl2l11 | Rat | berberine | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Berberine results in increased expression of BCL2L11 mRNA | CTD | PMID:26712469 |
Bcl2l11 | Rat | bis(2-chloroethyl) sulfide | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Mustard Gas results in increased expression of BCL2L11 mRNA | CTD | PMID:18955075 |
Bcl2l11 | Rat | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of BCL2L11 mRNA and Diethylhexyl Phthalate results in increased expression of BCL2L11 protein | CTD | PMID:22610992 and PMID:37979351 |
Bcl2l11 | Rat | bisphenol A | affects expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | bisphenol A affects the expression of BCL2L11 mRNA | CTD | PMID:21826169 |
Bcl2l11 | Rat | bisphenol A | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L11 mRNA | CTD | PMID:28628672 |
Bcl2l11 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of BCL2L11 gene | CTD | PMID:28505145 |
Bcl2l11 | Rat | bisphenol A | increases methylation | ISO | Bcl2l11 (Mus musculus) | 6480464 | bisphenol A results in increased methylation of BCL2L11 promoter | CTD | PMID:27312807 |
Bcl2l11 | Rat | bisphenol A | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | bisphenol A results in increased expression of BCL2L11 mRNA and bisphenol A results in increased expression of BCL2L11 protein | CTD | PMID:24909818 and PMID:32407858 |
Bcl2l11 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of BCL2L11 mRNA | CTD | PMID:25181051 |
Bcl2l11 | Rat | bisphenol A | increases methylation | ISO | BCL2L11 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of BCL2L11 gene | CTD | PMID:22576693 |
Bcl2l11 | Rat | bisphenol A | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of BCL2L11 mRNA | CTD | PMID:22576693 |
Bcl2l11 | Rat | bortezomib | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Bortezomib co-treated with romidepsin] results in increased expression of BCL2L11 protein more ... | CTD | PMID:15173094 and PMID:36509116 |
Bcl2l11 | Rat | bortezomib | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Bortezomib results in increased expression of BCL2L11 protein | CTD | PMID:16024631 more ... |
Bcl2l11 | Rat | bortezomib | increases activity | ISO | BCL2L11 (Homo sapiens) | 6480464 | Bortezomib results in increased activity of BCL2L11 protein | CTD | PMID:16446371 |
Bcl2l11 | Rat | bortezomib | increases response to substance | ISO | BCL2L11 (Homo sapiens) | 6480464 | BCL2L11 results in increased susceptibility to Bortezomib | CTD | PMID:18566236 |
Bcl2l11 | Rat | Brevetoxin B | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | brevetoxin 2 results in increased expression of BCL2L11 mRNA | CTD | PMID:20498034 |
Bcl2l11 | Rat | bufalin | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | bufalin results in increased expression of BCL2L11 protein | CTD | PMID:36924737 |
Bcl2l11 | Rat | cadmium dichloride | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of BCL2L11 | CTD | PMID:21787858 |
Bcl2l11 | Rat | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of BCL2L11 protein | CTD | PMID:28457857 |
Bcl2l11 | Rat | calcitriol | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of BCL2L11 mRNA | CTD | PMID:12071473 |
Bcl2l11 | Rat | cannabidiol | affects expression | EXP | | 6480464 | Cannabidiol affects the expression of BCL2L11 mRNA | CTD | PMID:38182033 |
Bcl2l11 | Rat | carbamazepine | affects expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of BCL2L11 mRNA | CTD | PMID:24752500 |
Bcl2l11 | Rat | carbaryl | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Carbaryl results in decreased expression of BCL2L11 mRNA | CTD | PMID:27829164 |
Bcl2l11 | Rat | carbon nanotube | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in increased expression of BCL2L11 mRNA | CTD | PMID:25554681 |
Bcl2l11 | Rat | chlorpyrifos | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of BCL2L11 mRNA | CTD | PMID:27737797 |
Bcl2l11 | Rat | chlorpyrifos | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | Chlorpyrifos promotes the reaction [Streptozocin results in increased expression of BCL2L11 mRNA] | CTD | PMID:33524429 |
Bcl2l11 | Rat | chromium(6+) | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | chromium hexavalent ion results in increased expression of BCL2L11 mRNA | CTD | PMID:17382205 |
Bcl2l11 | Rat | chromium(6+) | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | [sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased expression of BCL2L11 mRNA and Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased expression of BCL2L11 mRNA] | CTD | PMID:35643323 |
Bcl2l11 | Rat | chromium(6+) | affects expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of BCL2L11 mRNA | CTD | PMID:28472532 |
Bcl2l11 | Rat | cisplatin | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of BCL2L11 mRNA more ... | CTD | PMID:21092744 and PMID:27392435 |
Bcl2l11 | Rat | cisplatin | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of BCL2L11 mRNA | CTD | PMID:21092744 more ... |
Bcl2l11 | Rat | clofibrate | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of BCL2L11 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BCL2L11 mRNA] | CTD | PMID:17585979 |
Bcl2l11 | Rat | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of BCL2L11 mRNA | CTD | PMID:24386269 |
Bcl2l11 | Rat | cobalt dichloride | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | [cobaltous chloride co-treated with lipopolysaccharide more ... | CTD | PMID:32408695 |
Bcl2l11 | Rat | cobimetinib | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | cobimetinib results in increased expression of BCL2L11 protein and cobimetinib results in increased expression of BCL2L11 protein alternative form | CTD | PMID:22084396 |
Bcl2l11 | Rat | cobimetinib | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3 more ... | CTD | PMID:22084396 |
Bcl2l11 | Rat | cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of BCL2L11 mRNA | CTD | PMID:16076954 |
Bcl2l11 | Rat | copper atom | multiple interactions | EXP | | 6480464 | [Copper deficiency co-treated with tetrathiomolybdate] results in increased cleavage of BCL2L11 protein and [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of BCL2L11 protein | CTD | PMID:22276220 |
Bcl2l11 | Rat | copper(0) | multiple interactions | EXP | | 6480464 | [Copper deficiency co-treated with tetrathiomolybdate] results in increased cleavage of BCL2L11 protein and [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of BCL2L11 protein | CTD | PMID:22276220 |
Bcl2l11 | Rat | crizotinib | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | crizotinib results in increased expression of BCL2L11 protein | CTD | PMID:22729845 |
Bcl2l11 | Rat | crizotinib | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | BCL2L11 protein affects the reaction [crizotinib results in increased cleavage of CASP3 protein] and MET gene mutant form promotes the reaction [crizotinib results in increased expression of BCL2L11 protein] | CTD | PMID:22729845 |
Bcl2l11 | Rat | crizotinib | affects response to substance | ISO | BCL2L11 (Homo sapiens) | 6480464 | BCL2L11 protein affects the susceptibility to crizotinib | CTD | PMID:22729845 |
Bcl2l11 | Rat | crocidolite asbestos | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in decreased expression of BCL2L11 mRNA | CTD | PMID:18687144 |
Bcl2l11 | Rat | cucurbitacin B | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [cucurbitacin B co-treated with Gefitinib] results in increased expression of BCL2L11 mRNA | CTD | PMID:26183715 |
Bcl2l11 | Rat | cucurbitacin B | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | cucurbitacin B results in increased expression of BCL2L11 mRNA | CTD | PMID:26183715 |
Bcl2l11 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of BCL2L11 mRNA | CTD | PMID:25704630 |
Bcl2l11 | Rat | curcumin | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Curcumin results in increased expression of BCL2L11 mRNA | CTD | PMID:17332930 |
Bcl2l11 | Rat | curcumin | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [arsenic trioxide co-treated with Curcumin] results in increased expression of BCL2L11 protein | CTD | PMID:27430728 |
Bcl2l11 | Rat | cyclophosphamide | multiple interactions | EXP | | 6480464 | sacubitril and valsartan sodium hydrate drug combination inhibits the reaction [Cyclophosphamide results in increased expression of BCL2L11 mRNA] and Valsartan inhibits the reaction [Cyclophosphamide results in increased expression of BCL2L11 mRNA] | CTD | PMID:32197949 |
Bcl2l11 | Rat | cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of BCL2L11 mRNA | CTD | PMID:32197949 |
Bcl2l11 | Rat | D-glucose | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]] and resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] | CTD | PMID:25471227 |
Bcl2l11 | Rat | D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of BCL2L11 protein | CTD | PMID:25471227 |
Bcl2l11 | Rat | dactolisib | affects expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | dactolisib affects the expression of BCL2L11 protein | CTD | PMID:25640480 |
Bcl2l11 | Rat | dantrolene | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | Dantrolene inhibits the reaction [Halothane results in increased expression of BCL2L11 mRNA] | CTD | PMID:32795494 |
Bcl2l11 | Rat | DDE | affects expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene affects the expression of BCL2L11 mRNA | CTD | PMID:24576310 |
Bcl2l11 | Rat | deguelin | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | deguelin results in decreased expression of BCL2L11 mRNA | CTD | PMID:33512557 |
Bcl2l11 | Rat | dexamethasone | increases response to substance | ISO | BCL2L11 (Homo sapiens) | 6480464 | BCL2L11 protein results in increased susceptibility to Dexamethasone | CTD | PMID:14996839 |
Bcl2l11 | Rat | dexamethasone | increases response to substance | ISO | Bcl2l11 (Mus musculus) | 6480464 | BCL2L11 protein results in increased susceptibility to Dexamethasone | CTD | PMID:14996839 |
Bcl2l11 | Rat | dexamethasone | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Dexamethasone results in increased expression of BCL2L11 mRNA alternative form and Dexamethasone results in increased expression of BCL2L11 protein | CTD | PMID:14996839 and PMID:17953376 |
Bcl2l11 | Rat | dexamethasone | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L11 mRNA more ... | CTD | PMID:18515658 more ... |
Bcl2l11 | Rat | dexamethasone | increases phosphorylation | ISO | BCL2L11 (Homo sapiens) | 6480464 | Dexamethasone results in increased phosphorylation of BCL2L11 protein | CTD | PMID:20067466 |
Bcl2l11 | Rat | dexamethasone | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Dexamethasone results in increased expression of BCL2L11 mRNA | CTD | PMID:12782123 |
Bcl2l11 | Rat | Di-n-octyl phthalate | decreases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | di-n-octyl phthalate results in decreased expression of BCL2L11 protein | CTD | PMID:29128616 |
Bcl2l11 | Rat | diarsenic trioxide | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of BCL2L11 mRNA and Arsenic Trioxide results in increased expression of BCL2L11 protein | CTD | PMID:17203211 more ... |
Bcl2l11 | Rat | diarsenic trioxide | affects expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Arsenic Trioxide affects the expression of BCL2L11 protein | CTD | PMID:36509116 |
Bcl2l11 | Rat | diarsenic trioxide | increases degradation | ISO | BCL2L11 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased degradation of BCL2L11 protein | CTD | PMID:36509116 |
Bcl2l11 | Rat | diarsenic trioxide | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased degradation of BCL2L11 protein] more ... | CTD | PMID:21655183 more ... |
Bcl2l11 | Rat | dibenzo[a,l]pyrene | increases methylation | ISO | Bcl2l11 (Mus musculus) | 6480464 | dibenzo(a and l)pyrene results in increased methylation of BCL2L11 gene | CTD | PMID:28476633 |
Bcl2l11 | Rat | dibutyl phthalate | decreases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of BCL2L11 mRNA | CTD | PMID:17361019 and PMID:21266533 |
Bcl2l11 | Rat | diclofenac | affects expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Diclofenac affects the expression of BCL2L11 mRNA | CTD | PMID:24752500 |
Bcl2l11 | Rat | dicrotophos | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of BCL2L11 mRNA | CTD | PMID:28302478 |
Bcl2l11 | Rat | dieldrin | affects expression | EXP | | 6480464 | Dieldrin affects the expression of BCL2L11 mRNA | CTD | PMID:22546817 |
Bcl2l11 | Rat | diepoxybutane | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | diepoxybutane results in increased expression of BCL2L11 mRNA | CTD | PMID:29792945 |
Bcl2l11 | Rat | diethyl malate | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | diethyl malate results in increased expression of BCL2L11 mRNA | CTD | PMID:38498338 |
Bcl2l11 | Rat | dinophysistoxin 1 | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | dinophysistoxin 1 results in increased expression of BCL2L11 mRNA | CTD | PMID:28939011 |
Bcl2l11 | Rat | dioxygen | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein more ... | CTD | PMID:25472572 |
Bcl2l11 | Rat | dioxygen | multiple interactions | EXP | | 6480464 | [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BCL2L11 mRNA] and [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BCL2L11 mRNA | CTD | PMID:33729688 |
Bcl2l11 | Rat | diquat | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Diquat results in increased expression of BCL2L11 mRNA | CTD | PMID:26785375 and PMID:27057282 |
Bcl2l11 | Rat | diquat | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | procyanidin B2 inhibits the reaction [Diquat results in increased expression of BCL2L11 mRNA] | CTD | PMID:27057282 |
Bcl2l11 | Rat | disulfiram | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Disulfiram results in increased expression of BCL2L11 mRNA | CTD | PMID:34182011 |
Bcl2l11 | Rat | dorsomorphin | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:35530161 |
Bcl2l11 | Rat | doxorubicin | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Doxorubicin] results in decreased phosphorylation of BCL2L11 protein more ... | CTD | PMID:17339365 and PMID:20856197 |
Bcl2l11 | Rat | doxorubicin | multiple interactions | EXP | | 6480464 | 5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1 more ... | CTD | PMID:32075913 |
Bcl2l11 | Rat | doxorubicin | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of BCL2L11 protein | CTD | PMID:25339540 |
Bcl2l11 | Rat | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BCL2L11 mRNA and Doxorubicin results in increased expression of BCL2L11 protein | CTD | PMID:26318906 and PMID:32075913 |
Bcl2l11 | Rat | doxorubicin | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of BCL2L11 protein | CTD | PMID:17339365 |
Bcl2l11 | Rat | efavirenz | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | efavirenz metabolite results in increased expression of BCL2L11 mRNA more ... | CTD | PMID:21958719 |
Bcl2l11 | Rat | efavirenz | increases response to substance | ISO | BCL2L11 (Homo sapiens) | 6480464 | BCL2L11 protein results in increased susceptibility to efavirenz metabolite | CTD | PMID:21958719 |
Bcl2l11 | Rat | elemental selenium | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with Selenium] more ... | CTD | PMID:17339365 |
Bcl2l11 | Rat | elemental selenium | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Selenium results in increased expression of BCL2L11 protein | CTD | PMID:17339365 |
Bcl2l11 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of BCL2L11 mRNA | CTD | PMID:29391264 |
Bcl2l11 | Rat | enniatin | decreases expression | EXP | | 6480464 | enniatins results in decreased expression of BCL2L11 mRNA | CTD | PMID:27163883 |
Bcl2l11 | Rat | entinostat | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | entinostat results in decreased expression of BCL2L11 mRNA | CTD | PMID:26272509 |
Bcl2l11 | Rat | entinostat | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2L11 mRNA | CTD | PMID:27188386 |
Bcl2l11 | Rat | epichlorohydrin | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Epichlorohydrin results in decreased expression of BCL2L11 mRNA | CTD | PMID:29792945 |
Bcl2l11 | Rat | epoxiconazole | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of BCL2L11 mRNA | CTD | PMID:35436446 |
Bcl2l11 | Rat | erlotinib hydrochloride | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Erlotinib Hydrochloride results in increased expression of BCL2L11 protein | CTD | PMID:30171258 |
Bcl2l11 | Rat | erlotinib hydrochloride | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | Harmine promotes the reaction [Erlotinib Hydrochloride results in increased expression of BCL2L11 protein] | CTD | PMID:30171258 |
Bcl2l11 | Rat | ethanol | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Ethanol results in increased expression of BCL2L11 mRNA | CTD | PMID:24095927 |
Bcl2l11 | Rat | ethanol | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Ethanol co-treated with FOXO3 protein] results in increased expression of BCL2L11 mRNA more ... | CTD | PMID:26470730 |
Bcl2l11 | Rat | ethyl methanesulfonate | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of BCL2L11 mRNA | CTD | PMID:23649840 |
Bcl2l11 | Rat | ferric oxide | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | ferric oxide analog results in increased expression of BCL2L11 mRNA and ferric oxide analog results in increased expression of BCL2L11 protein | CTD | PMID:24525745 and PMID:25086211 |
Bcl2l11 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of BCL2L11 mRNA and Flutamide results in increased expression of BCL2L11 protein | CTD | PMID:20850791 and PMID:24793618 |
Bcl2l11 | Rat | flutamide | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Flutamide results in increased expression of BCL2L11 protein | CTD | PMID:16301331 |
Bcl2l11 | Rat | flutamide | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | CBL protein affects the reaction [Flutamide results in increased expression of BCL2L11 protein] | CTD | PMID:16301331 |
Bcl2l11 | Rat | fluvastatin | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [zoledronic acid co-treated with fluvastatin] results in increased expression of BCL2L11 mRNA | CTD | PMID:16996129 |
Bcl2l11 | Rat | folic acid | affects expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Folic Acid affects the expression of BCL2L11 mRNA | CTD | PMID:16361273 |
Bcl2l11 | Rat | formaldehyde | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of BCL2L11 mRNA | CTD | PMID:23649840 |
Bcl2l11 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of BCL2L11 mRNA | CTD | PMID:20562052 more ... |
Bcl2l11 | Rat | furosemide | affects expression | EXP | | 6480464 | Furosemide affects the expression of BCL2L11 mRNA | CTD | PMID:17497460 |
Bcl2l11 | Rat | gallic acid | decreases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Gallic Acid results in decreased expression of BCL2L11 mRNA | CTD | PMID:29205955 |
Bcl2l11 | Rat | gefitinib | increases response to substance | ISO | BCL2L11 (Homo sapiens) | 6480464 | BCL2L11 protein results in increased susceptibility to gefitinib | CTD | PMID:20237869 |
Bcl2l11 | Rat | gefitinib | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [cucurbitacin B co-treated with Gefitinib] results in increased expression of BCL2L11 mRNA | CTD | PMID:26183715 |
Bcl2l11 | Rat | gemcitabine | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Gemcitabine results in increased expression of BCL2L11 mRNA | CTD | PMID:17039268 |
Bcl2l11 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of BCL2L11 mRNA | CTD | PMID:33387578 |
Bcl2l11 | Rat | Gingerenone A | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | gingerenone A results in increased expression of BCL2L11 protein modified form | CTD | PMID:26242912 |
Bcl2l11 | Rat | glucose | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]] and resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] | CTD | PMID:25471227 |
Bcl2l11 | Rat | glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of BCL2L11 protein | CTD | PMID:25471227 |
Bcl2l11 | Rat | gold atom | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Gold analog results in decreased expression of BCL2L11 mRNA | CTD | PMID:36057382 |
Bcl2l11 | Rat | gold(0) | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Gold analog results in decreased expression of BCL2L11 mRNA | CTD | PMID:36057382 |
Bcl2l11 | Rat | gossypol | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Gossypol results in increased expression of BCL2L11 protein | CTD | PMID:18840529 |
Bcl2l11 | Rat | GW 6471 | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | GW 6471 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L11 protein] | CTD | PMID:37979351 |
Bcl2l11 | Rat | halothane | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Halothane results in increased expression of BCL2L11 mRNA | CTD | PMID:32795494 |
Bcl2l11 | Rat | halothane | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | [Ryanodine co-treated with Halothane] results in increased expression of BCL2L11 mRNA and Dantrolene inhibits the reaction [Halothane results in increased expression of BCL2L11 mRNA] | CTD | PMID:32795494 |
Bcl2l11 | Rat | harmine | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | Harmine promotes the reaction [Erlotinib Hydrochloride results in increased expression of BCL2L11 protein] | CTD | PMID:30171258 |
Bcl2l11 | Rat | hydrogen peroxide | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Hydrogen Peroxide results in increased expression of BCL2L11 mRNA | CTD | PMID:27057282 |
Bcl2l11 | Rat | hydrogen peroxide | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | procyanidin B2 inhibits the reaction [Hydrogen Peroxide results in increased expression of BCL2L11 mRNA] | CTD | PMID:27057282 |
Bcl2l11 | Rat | ibrutinib | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | ibrutinib promotes the reaction [(+)-JQ1 compound results in increased expression of BCL2L11 protein] | CTD | PMID:26254443 |
Bcl2l11 | Rat | icariin | affects expression | EXP | | 6480464 | icariin affects the expression of BCL2L11 protein | CTD | PMID:25472572 |
Bcl2l11 | Rat | icariin | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein] | CTD | PMID:25472572 |
Bcl2l11 | Rat | indole-3-methanol | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | indole-3-carbinol results in increased expression of BCL2L11 protein | CTD | PMID:33118390 and PMID:34085558 |
Bcl2l11 | Rat | indometacin | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L11 mRNA | CTD | PMID:28628672 |
Bcl2l11 | Rat | isoflurane | decreases expression | EXP | | 6480464 | Isoflurane results in decreased expression of BCL2L11 mRNA | CTD | PMID:16978161 |
Bcl2l11 | Rat | isoprenaline | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of BCL2L11 protein | CTD | PMID:14996839 |
Bcl2l11 | Rat | isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of BCL2L11 mRNA | CTD | PMID:24286936 |
Bcl2l11 | Rat | isoprenaline | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Isoproterenol results in increased expression of BCL2L11 mRNA | CTD | PMID:24286936 |
Bcl2l11 | Rat | ketoconazole | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Ketoconazole results in increased expression of BCL2L11 mRNA | CTD | PMID:25808816 |
Bcl2l11 | Rat | lead diacetate | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | lead acetate results in increased expression of BCL2L11 mRNA | CTD | PMID:21829687 |
Bcl2l11 | Rat | lovastatin | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [Lovastatin results in increased expression of BCL2L11 protein] | CTD | PMID:18766339 |
Bcl2l11 | Rat | lovastatin | multiple interactions | EXP | | 6480464 | Lovastatin inhibits the reaction [Cholesterol and Dietary results in increased expression of BCL2L11 protein] | CTD | PMID:35734936 |
Bcl2l11 | Rat | lovastatin | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Lovastatin results in increased expression of BCL2L11 protein | CTD | PMID:18766339 |
Bcl2l11 | Rat | LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]] | CTD | PMID:25471227 |
Bcl2l11 | Rat | LY294002 | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of BCL2L11 protein alternative form | CTD | PMID:21179458 |
Bcl2l11 | Rat | LY294002 | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rebamipide results in decreased expression of BCL2L11 protein] more ... | CTD | PMID:20856197 more ... |
Bcl2l11 | Rat | maneb | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Maneb results in increased expression of BCL2L11 protein | CTD | PMID:18266926 |
Bcl2l11 | Rat | maneb | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Paraquat co-treated with Maneb] results in increased expression of BCL2L11 protein | CTD | PMID:18266926 |
Bcl2l11 | Rat | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of BCL2L11 protein | CTD | PMID:25732873 |
Bcl2l11 | Rat | manganese(II) chloride | decreases expression | EXP | | 6480464 | manganese chloride results in decreased expression of BCL2L11 mRNA | CTD | PMID:28801915 |
Bcl2l11 | Rat | medroxyprogesterone acetate | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of BCL2L11 protein | CTD | PMID:16709600 |
Bcl2l11 | Rat | melatonin | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased expression of BCL2L11 mRNA] | CTD | PMID:35643323 |
Bcl2l11 | Rat | mercury atom | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Mercury results in decreased expression of BCL2L11 mRNA | CTD | PMID:19937285 |
Bcl2l11 | Rat | mercury dibromide | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | mercuric bromide results in decreased expression of BCL2L11 mRNA | CTD | PMID:26272509 |
Bcl2l11 | Rat | mercury dibromide | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2L11 mRNA | CTD | PMID:27188386 |
Bcl2l11 | Rat | mercury(0) | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Mercury results in decreased expression of BCL2L11 mRNA | CTD | PMID:19937285 |
Bcl2l11 | Rat | methamphetamine | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Methamphetamine results in increased expression of BCL2L11 protein | CTD | PMID:23820845 |
Bcl2l11 | Rat | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of BCL2L11 protein | CTD | PMID:34214594 |
Bcl2l11 | Rat | methamphetamine | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of BCL2L11 protein] and DDIT3 protein affects the reaction [Methamphetamine results in increased expression of BCL2L11 protein] | CTD | PMID:34214594 |
Bcl2l11 | Rat | methamphetamine | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [N-Methyl-3 more ... | CTD | PMID:23820845 |
Bcl2l11 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of BCL2L11 gene | CTD | PMID:35440735 |
Bcl2l11 | Rat | methyl methanesulfonate | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of BCL2L11 mRNA | CTD | PMID:23649840 |
Bcl2l11 | Rat | methylmercury chloride | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of BCL2L11 mRNA | CTD | PMID:28001369 |
Bcl2l11 | Rat | methylparaben | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | methylparaben results in increased expression of BCL2L11 mRNA | CTD | PMID:24481588 |
Bcl2l11 | Rat | methylseleninic acid | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with methylselenic acid] more ... | CTD | PMID:17339365 and PMID:18790785 |
Bcl2l11 | Rat | methylseleninic acid | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | methylselenic acid results in increased expression of BCL2L11 mRNA and methylselenic acid results in increased expression of BCL2L11 protein | CTD | PMID:17339365 and PMID:28161410 |
Bcl2l11 | Rat | methylseleninic acid | increases cleavage | ISO | BCL2L11 (Homo sapiens) | 6480464 | methylselenic acid results in increased cleavage of BCL2L11 protein | CTD | PMID:18790785 |
Bcl2l11 | Rat | microcystin-LR | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | cyanoginosin LR results in increased expression of BCL2L11 mRNA | CTD | PMID:17654400 |
Bcl2l11 | Rat | Mitotane | increases expression | EXP | | 6480464 | Mitotane results in increased expression of BCL2L11 mRNA | CTD | PMID:23485034 |
Bcl2l11 | Rat | MK-2206 | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [mirdametinib co-treated with MK 2206] results in increased expression of BCL2L11 protein more ... | CTD | PMID:27634878 |
Bcl2l11 | Rat | mono(2-ethylhexyl) phthalate | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L11 protein | CTD | PMID:37979351 |
Bcl2l11 | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | GW 6471 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L11 protein] | CTD | PMID:37979351 |
Bcl2l11 | Rat | monodansylcadaverine | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | monodansylcadaverine results in increased expression of BCL2L11 protein | CTD | PMID:16170020 |
Bcl2l11 | Rat | monosodium L-glutamate | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Sodium Glutamate results in increased expression of BCL2L11 mRNA | CTD | PMID:19001666 |
Bcl2l11 | Rat | monosodium L-glutamate | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of BCL2L11 mRNA | CTD | PMID:19001666 |
Bcl2l11 | Rat | morphine | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Morphine results in increased expression of BCL2L11 protein | CTD | PMID:19292871 |
Bcl2l11 | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [[Bortezomib co-treated with romidepsin] results in increased expression of BCL2L11 protein] | CTD | PMID:15173094 |
Bcl2l11 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arsenic Trioxide results in increased degradation of BCL2L11 protein] | CTD | PMID:36509116 |
Bcl2l11 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of BCL2L11 mRNA | CTD | PMID:18266926 |
Bcl2l11 | Rat | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L11 mRNA | CTD | PMID:28801915 |
Bcl2l11 | Rat | N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | MIR181C mRNA inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BCL2L11 mRNA] and MIR181C mRNA inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BCL2L11 protein] | CTD | PMID:28770951 |
Bcl2l11 | Rat | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of BCL2L11 mRNA and 1-Methyl-4-phenylpyridinium results in increased expression of BCL2L11 protein | CTD | PMID:28770951 |
Bcl2l11 | Rat | N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | EXP | | 6480464 | [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein and S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein] | CTD | PMID:16030430 |
Bcl2l11 | Rat | N-nitrosodiethylamine | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of BCL2L11 mRNA | CTD | PMID:24535843 |
Bcl2l11 | Rat | nickel atom | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | trichostatin A inhibits the reaction [Nickel affects the expression of BCL2L11 mRNA] | CTD | PMID:14575637 |
Bcl2l11 | Rat | nickel atom | affects expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Nickel affects the expression of BCL2L11 mRNA | CTD | PMID:14575637 |
Bcl2l11 | Rat | nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of BCL2L11 mRNA | CTD | PMID:22110744 |
Bcl2l11 | Rat | nickel sulfate | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of BCL2L11 mRNA | CTD | PMID:17382205 |
Bcl2l11 | Rat | nicotinamide | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Berberine co-treated with Niacinamide] results in increased expression of BCL2L11 mRNA and Niacinamide promotes the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein] | CTD | PMID:25472572 and PMID:26712469 |
Bcl2l11 | Rat | nicotinamide | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Niacinamide results in increased expression of BCL2L11 mRNA | CTD | PMID:26712469 |
Bcl2l11 | Rat | nimustine | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Nimustine results in increased expression of BCL2L11 mRNA and Nimustine results in increased expression of BCL2L11 protein | CTD | PMID:26418950 |
Bcl2l11 | Rat | nimustine | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | BCL2L11 mutant form inhibits the reaction [Nimustine results in increased cleavage of CASP9 protein] and pyrazolanthrone inhibits the reaction [Nimustine results in increased expression of BCL2L11 mRNA] | CTD | PMID:26418950 |
Bcl2l11 | Rat | NORCANTHARIDIN | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | norcantharidin results in increased expression of BCL2L11 protein alternative form | CTD | PMID:29193574 |
Bcl2l11 | Rat | ochratoxin A | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | ochratoxin A results in decreased expression of BCL2L11 mRNA | CTD | PMID:30559759 and PMID:30763683 |
Bcl2l11 | Rat | okadaic acid | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of BCL2L11 mRNA | CTD | PMID:28939011 |
Bcl2l11 | Rat | omipalisib | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [trametinib co-treated with omipalisib] results in increased expression of BCL2L11 protein | CTD | PMID:22733540 |
Bcl2l11 | Rat | osthole | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | osthol results in increased expression of BCL2L11 protein alternative form | CTD | PMID:29319219 |
Bcl2l11 | Rat | ozone | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BCL2L11 mRNA more ... | CTD | PMID:32699268 and PMID:32845096 |
Bcl2l11 | Rat | ozone | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of BCL2L11 mRNA | CTD | PMID:34911549 |
Bcl2l11 | Rat | p-chloromercuribenzoic acid | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of BCL2L11 mRNA | CTD | PMID:26272509 |
Bcl2l11 | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2L11 mRNA | CTD | PMID:27188386 |
Bcl2l11 | Rat | paclitaxel | affects response to substance | ISO | Bcl2l11 (Mus musculus) | 6480464 | BCL2L11 protein affects the susceptibility to Paclitaxel | CTD | PMID:17652622 |
Bcl2l11 | Rat | panobinostat | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | panobinostat results in decreased expression of BCL2L11 mRNA | CTD | PMID:26272509 |
Bcl2l11 | Rat | panobinostat | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | (+)-JQ1 compound promotes the reaction [Panobinostat results in increased expression of BCL2L11 protein] more ... | CTD | PMID:24435446 and PMID:27188386 |
Bcl2l11 | Rat | panobinostat | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | panobinostat results in increased expression of BCL2L11 protein | CTD | PMID:24435446 |
Bcl2l11 | Rat | paracetamol | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of BCL2L11 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BCL2L11 mRNA] | CTD | PMID:17585979 |
Bcl2l11 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of BCL2L11 mRNA | CTD | PMID:33387578 |
Bcl2l11 | Rat | paracetamol | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of BCL2L11 mRNA | CTD | PMID:26690555 |
Bcl2l11 | Rat | paracetamol | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of BCL2L11 mRNA | CTD | PMID:21420995 and PMID:25704631 |
Bcl2l11 | Rat | paracetamol | affects expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Acetaminophen affects the expression of BCL2L11 mRNA | CTD | PMID:17562736 |
Bcl2l11 | Rat | paraquat | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Paraquat results in decreased expression of BCL2L11 mRNA | CTD | PMID:18836921 |
Bcl2l11 | Rat | paraquat | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Paraquat co-treated with Maneb] results in increased expression of BCL2L11 protein | CTD | PMID:18266926 |
Bcl2l11 | Rat | paraquat | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Paraquat results in increased expression of BCL2L11 protein | CTD | PMID:18266926 |
Bcl2l11 | Rat | paraquat | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | FOXO3 mutant form inhibits the reaction [Paraquat results in increased expression of BCL2L11 mRNA] | CTD | PMID:23620592 |
Bcl2l11 | Rat | paraquat | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Paraquat results in increased expression of BCL2L11 mRNA | CTD | PMID:23620592 |
Bcl2l11 | Rat | patulin | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Patulin results in increased expression of BCL2L11 mRNA | CTD | PMID:21844328 |
Bcl2l11 | Rat | PD 0325901 | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | mirdametinib results in increased expression of BCL2L11 protein | CTD | PMID:24576621 and PMID:27634878 |
Bcl2l11 | Rat | PD 0325901 | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [mirdametinib co-treated with MK 2206] results in increased expression of BCL2L11 protein more ... | CTD | PMID:24576621 and PMID:27634878 |
Bcl2l11 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | FOXO3 protein affects the reaction [perfluorooctane sulfonic acid results in increased expression of BCL2L11 protein] | CTD | PMID:31588057 |
Bcl2l11 | Rat | perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of BCL2L11 protein | CTD | PMID:31588057 |
Bcl2l11 | Rat | perfluorooctanoic acid | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of BCL2L11 protein | CTD | PMID:35123991 |
Bcl2l11 | Rat | pevonedistat | affects expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | pevonedistat affects the expression of BCL2L11 mRNA and pevonedistat affects the expression of BCL2L11 protein | CTD | PMID:24634471 |
Bcl2l11 | Rat | PF-4708671 | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [NVP-BSK805 co-treated with PF-4708671] results in increased expression of BCL2L11 protein modified form | CTD | PMID:26242912 |
Bcl2l11 | Rat | phenobarbital | decreases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of BCL2L11 mRNA | CTD | PMID:19270015 |
Bcl2l11 | Rat | phenobarbital | affects expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Phenobarbital affects the expression of BCL2L11 mRNA | CTD | PMID:23091169 |
Bcl2l11 | Rat | phenobarbital | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of BCL2L11 mRNA | CTD | PMID:25270620 |
Bcl2l11 | Rat | phenylmercury acetate | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of BCL2L11 mRNA | CTD | PMID:26272509 |
Bcl2l11 | Rat | phenylmercury acetate | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2L11 mRNA | CTD | PMID:27188386 |
Bcl2l11 | Rat | phloretin | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | Phloretin inhibits the reaction [[cobaltous chloride co-treated with lipopolysaccharide and E coli O55-B5] results in increased expression of BCL2L11 protein] | CTD | PMID:32408695 |
Bcl2l11 | Rat | picoxystrobin | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | picoxystrobin results in decreased expression of BCL2L11 mRNA | CTD | PMID:33512557 |
Bcl2l11 | Rat | pinostrobin | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | pinostrobin results in increased expression of BCL2L11 mRNA | CTD | PMID:37777166 |
Bcl2l11 | Rat | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of BCL2L11 mRNA | CTD | PMID:12832660 |
Bcl2l11 | Rat | ponatinib | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | (+)-JQ1 compound promotes the reaction [ponatinib results in increased expression of BCL2L11 protein] and ponatinib promotes the reaction [(+)-JQ1 compound results in increased expression of BCL2L11 protein] | CTD | PMID:25053825 |
Bcl2l11 | Rat | ponatinib | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | ponatinib results in increased expression of BCL2L11 protein | CTD | PMID:25053825 |
Bcl2l11 | Rat | potassium chromate | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of BCL2L11 mRNA | CTD | PMID:17382205 |
Bcl2l11 | Rat | Pramanicin | affects response to substance | ISO | BCL2L11 (Homo sapiens) | 6480464 | BCL2L11 protein affects the susceptibility to pramanicin | CTD | PMID:23441183 |
Bcl2l11 | Rat | Pramanicin | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | pramanicin analog results in increased expression of BCL2L11 protein | CTD | PMID:23441183 |
Bcl2l11 | Rat | proanthocyanidin | decreases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Proanthocyanidins results in decreased expression of BCL2L11 mRNA | CTD | PMID:29205955 |
Bcl2l11 | Rat | prochloraz | increases expression | EXP | | 6480464 | prochloraz results in increased expression of BCL2L11 mRNA | CTD | PMID:29038839 |
Bcl2l11 | Rat | procyanidin B2 | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | procyanidin B2 inhibits the reaction [Diquat results in increased expression of BCL2L11 mRNA] and procyanidin B2 inhibits the reaction [Hydrogen Peroxide results in increased expression of BCL2L11 mRNA] | CTD | PMID:27057282 |
Bcl2l11 | Rat | propylparaben | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | propylparaben results in increased expression of BCL2L11 mRNA | CTD | PMID:24481588 |
Bcl2l11 | Rat | protein kinase inhibitor | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of BCL2L11 mRNA] | CTD | PMID:28003376 |
Bcl2l11 | Rat | pyrethrins | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Pyrethrins results in increased expression of BCL2L11 mRNA | CTD | PMID:35321623 |
Bcl2l11 | Rat | quercetin | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Quercetin results in increased expression of BCL2L11 mRNA and Quercetin results in increased expression of BCL2L11 protein | CTD | PMID:25339540 and PMID:30152185 |
Bcl2l11 | Rat | quercetin | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of BCL2L11 protein | CTD | PMID:20438634 |
Bcl2l11 | Rat | quizartinib | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | (+)-JQ1 compound promotes the reaction [quizartinib results in increased expression of BCL2L11 protein] and quizartinib promotes the reaction [(+)-JQ1 compound results in increased expression of BCL2L11 protein] | CTD | PMID:25053825 |
Bcl2l11 | Rat | quizartinib | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | quizartinib results in increased expression of BCL2L11 protein | CTD | PMID:25053825 |
Bcl2l11 | Rat | raloxifene | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Raloxifene Hydrochloride results in increased expression of BCL2L11 mRNA | CTD | PMID:19429434 |
Bcl2l11 | Rat | reactive oxygen species | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [[[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased phosphorylation of and results in increased stability of TP53 protein] which results in decreased expression of BCL2L11 protein | CTD | PMID:27634759 |
Bcl2l11 | Rat | Rebamipide | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | rebamipide results in decreased expression of BCL2L11 protein | CTD | PMID:29054700 |
Bcl2l11 | Rat | Rebamipide | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rebamipide results in decreased expression of BCL2L11 protein] more ... | CTD | PMID:29054700 |
Bcl2l11 | Rat | remdesivir | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | remdesivir results in increased expression of BCL2L11 protein | CTD | PMID:35417658 |
Bcl2l11 | Rat | resveratrol | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | BCL2L11 protein promotes the reaction [resveratrol results in increased activity of BAK1 protein] more ... | CTD | PMID:21179458 more ... |
Bcl2l11 | Rat | resveratrol | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]] and resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] | CTD | PMID:25471227 |
Bcl2l11 | Rat | resveratrol | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | resveratrol results in increased expression of BCL2L11 protein | CTD | PMID:20026400 and PMID:21980390 |
Bcl2l11 | Rat | resveratrol | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | resveratrol results in increased expression of BCL2L11 protein and resveratrol results in increased expression of BCL2L11 protein alternative form | CTD | PMID:17636462 more ... |
Bcl2l11 | Rat | resveratrol | increases response to substance | ISO | BCL2L11 (Homo sapiens) | 6480464 | BCL2L11 protein results in increased susceptibility to resveratrol | CTD | PMID:22245142 |
Bcl2l11 | Rat | romidepsin | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Bortezomib co-treated with romidepsin] results in increased expression of BCL2L11 protein more ... | CTD | PMID:15173094 and PMID:27634878 |
Bcl2l11 | Rat | romidepsin | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | romidepsin results in increased expression of BCL2L11 protein | CTD | PMID:15069698 more ... |
Bcl2l11 | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of BCL2L11 mRNA | CTD | PMID:28374803 |
Bcl2l11 | Rat | rotenone | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of BCL2L11 mRNA | CTD | PMID:33512557 and PMID:36586010 |
Bcl2l11 | Rat | ryanodine | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | [Ryanodine co-treated with Halothane] results in increased expression of BCL2L11 mRNA | CTD | PMID:32795494 |
Bcl2l11 | Rat | S-allylcysteine | multiple interactions | EXP | | 6480464 | S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein] | CTD | PMID:16030430 |
Bcl2l11 | Rat | sapanisertib | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | sapanisertib results in increased expression of BCL2L11 mRNA and sapanisertib results in increased expression of BCL2L11 protein | CTD | PMID:26536665 |
Bcl2l11 | Rat | sarin | increases expression | EXP | | 6480464 | Sarin results in increased expression of BCL2L11 mRNA | CTD | PMID:16733813 |
Bcl2l11 | Rat | SB 203580 | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [sodium arsenite results in increased phosphorylation of BCL2L11 protein] | CTD | PMID:16818494 |
Bcl2l11 | Rat | SB 431542 | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 |
Bcl2l11 | Rat | Se-methyl-L-selenocysteine | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | selenomethylselenocysteine metabolite results in increased expression of BCL2L11 mRNA | CTD | PMID:25321483 |
Bcl2l11 | Rat | Se-methylselenocysteine | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | selenomethylselenocysteine metabolite results in increased expression of BCL2L11 mRNA | CTD | PMID:25321483 |
Bcl2l11 | Rat | selenium atom | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with Selenium] more ... | CTD | PMID:17339365 |
Bcl2l11 | Rat | selenium atom | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Selenium results in increased expression of BCL2L11 protein | CTD | PMID:17339365 |
Bcl2l11 | Rat | selumetinib | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | AZD 6244 results in increased expression of BCL2L11 protein | CTD | PMID:22729845 |
Bcl2l11 | Rat | serpentine asbestos | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | PRKD1 protein affects the reaction [Asbestos more ... | CTD | PMID:19116364 |
Bcl2l11 | Rat | serpentine asbestos | decreases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Asbestos and Serpentine results in decreased expression of BCL2L11 protein | CTD | PMID:19116364 |
Bcl2l11 | Rat | silicon dioxide | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of BCL2L11 mRNA and Silicon Dioxide results in decreased expression of BCL2L11 mRNA | CTD | PMID:25351596 and PMID:25895662 |
Bcl2l11 | Rat | silicon dioxide | decreases methylation | ISO | BCL2L11 (Homo sapiens) | 6480464 | Silicon Dioxide results in decreased methylation of BCL2L11 gene | CTD | PMID:34973136 |
Bcl2l11 | Rat | silicon dioxide | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of BCL2L11 mRNA | CTD | PMID:19073995 |
Bcl2l11 | Rat | sirolimus | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Cisplatin inhibits the reaction [[Sirolimus results in increased phosphorylation of AKT1 protein] which results in increased phosphorylation of FOXO3 protein]] which results in increased expression of BCL2L11 protein more ... | CTD | PMID:21092744 and PMID:29054700 |
Bcl2l11 | Rat | sirolimus | decreases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Sirolimus results in decreased expression of BCL2L11 protein | CTD | PMID:18097008 |
Bcl2l11 | Rat | sirolimus | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Sirolimus results in increased expression of BCL2L11 protein | CTD | PMID:21092744 |
Bcl2l11 | Rat | sodium arsenite | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of BCL2L11 mRNA | CTD | PMID:16166651 |
Bcl2l11 | Rat | sodium arsenite | increases response to substance | EXP | | 6480464 | BCL2L11 protein results in increased susceptibility to sodium arsenite | CTD | PMID:16818494 |
Bcl2l11 | Rat | sodium arsenite | increases phosphorylation | EXP | | 6480464 | sodium arsenite results in increased phosphorylation of BCL2L11 protein | CTD | PMID:16818494 |
Bcl2l11 | Rat | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of BCL2L11 protein alternative form | CTD | PMID:20830294 |
Bcl2l11 | Rat | sodium arsenite | decreases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of BCL2L11 mRNA | CTD | PMID:19822182 |
Bcl2l11 | Rat | sodium arsenite | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [sodium arsenite results in increased phosphorylation of BCL2L11 protein] more ... | CTD | PMID:16818494 and PMID:20830294 |
Bcl2l11 | Rat | sodium arsenite | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | CEP-11004 inhibits the reaction [sodium arsenite results in increased expression of BCL2L11 protein] more ... | CTD | PMID:16166651 |
Bcl2l11 | Rat | sodium chloride | multiple interactions | EXP | | 6480464 | [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein and S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein] | CTD | PMID:16030430 |
Bcl2l11 | Rat | sodium chromate | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | [sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased expression of BCL2L11 mRNA and Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased expression of BCL2L11 mRNA] | CTD | PMID:35643323 |
Bcl2l11 | Rat | sorafenib | affects localization | ISO | BCL2L11 (Homo sapiens) | 6480464 | sorafenib affects the localization of BCL2L11 protein | CTD | PMID:18200035 |
Bcl2l11 | Rat | sorafenib | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | sorafenib results in increased expression of BCL2L11 protein | CTD | PMID:18200035 |
Bcl2l11 | Rat | sorafenib | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | sorafenib results in decreased expression of BCL2L11 protein | CTD | PMID:16109713 |
Bcl2l11 | Rat | sorafenib | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [sorafenib co-treated with 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3 and 2-d)pyrimidine] results in increased expression of BCL2L11 protein | CTD | PMID:23036488 |
Bcl2l11 | Rat | streptozocin | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Streptozocin results in increased expression of BCL2L11 mRNA | CTD | PMID:33524429 |
Bcl2l11 | Rat | streptozocin | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | Chlorpyrifos promotes the reaction [Streptozocin results in increased expression of BCL2L11 mRNA] | CTD | PMID:33524429 |
Bcl2l11 | Rat | succimer | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of BCL2L11 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BCL2L11 mRNA | CTD | PMID:21641980 and PMID:26378955 |
Bcl2l11 | Rat | succimer | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BCL2L11 mRNA | CTD | PMID:26378955 |
Bcl2l11 | Rat | sunitinib | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of BCL2L11 mRNA | CTD | PMID:31533062 |
Bcl2l11 | Rat | tamoxifen | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | Tamoxifen promotes the reaction [methylselenic acid results in increased cleavage of BCL2L11 protein] | CTD | PMID:18790785 |
Bcl2l11 | Rat | tanespimycin | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | tanespimycin results in increased expression of BCL2L11 protein | CTD | PMID:24784839 |
Bcl2l11 | Rat | taurine | multiple interactions | EXP | | 6480464 | Taurine inhibits the reaction [sodium arsenite results in increased expression of BCL2L11 protein alternative form] | CTD | PMID:20830294 |
Bcl2l11 | Rat | temozolomide | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | temozolomide results in increased expression of BCL2L11 mRNA and temozolomide results in increased expression of BCL2L11 protein | CTD | PMID:26418950 |
Bcl2l11 | Rat | temozolomide | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | BCL2L11 mutant form inhibits the reaction [temozolomide results in increased cleavage of CASP9 protein] and pyrazolanthrone inhibits the reaction [temozolomide results in increased expression of BCL2L11 mRNA] | CTD | PMID:26418950 |
Bcl2l11 | Rat | testosterone | increases expression | EXP | | 6480464 | Testosterone deficiency results in increased expression of BCL2L11 protein | CTD | PMID:20850791 |
Bcl2l11 | Rat | testosterone | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of BCL2L11 mRNA | CTD | PMID:33359661 |
Bcl2l11 | Rat | tetrachloromethane | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of BCL2L11 mRNA and Carbon Tetrachloride results in increased expression of BCL2L11 protein | CTD | PMID:17482686 |
Bcl2l11 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of BCL2L11 mRNA | CTD | PMID:33387578 |
Bcl2l11 | Rat | tetrachloromethane | multiple interactions | ISO | Bcl2l11 (Mus musculus) | 6480464 | PLG protein affects the reaction [Carbon Tetrachloride results in increased expression of BCL2L11 protein] | CTD | PMID:17482686 |
Bcl2l11 | Rat | tetrathiomolybdate(2-) | multiple interactions | EXP | | 6480464 | [Copper deficiency co-treated with tetrathiomolybdate] results in increased cleavage of BCL2L11 protein and [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of BCL2L11 protein | CTD | PMID:22276220 |
Bcl2l11 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of BCL2L11 mRNA | CTD | PMID:23411599 and PMID:34492290 |
Bcl2l11 | Rat | thiram | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Thiram results in increased expression of BCL2L11 mRNA | CTD | PMID:38568856 |
Bcl2l11 | Rat | titanium dioxide | decreases methylation | ISO | Bcl2l11 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of BCL2L11 gene and titanium dioxide results in decreased methylation of BCL2L11 promoter | CTD | PMID:35295148 |
Bcl2l11 | Rat | Tomentosin | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | tomentosin results in increased expression of BCL2L11 protein | CTD | PMID:32787465 |
Bcl2l11 | Rat | trametinib | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [trametinib co-treated with omipalisib] results in increased expression of BCL2L11 protein | CTD | PMID:22733540 |
Bcl2l11 | Rat | trametinib | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | trametinib results in increased expression of BCL2L11 protein | CTD | PMID:22733540 |
Bcl2l11 | Rat | Tributyltin oxide | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of BCL2L11 mRNA | CTD | PMID:22434021 |
Bcl2l11 | Rat | trichostatin A | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:14575637 and PMID:27188386 |
Bcl2l11 | Rat | trichostatin A | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of BCL2L11 mRNA | CTD | PMID:24935251 and PMID:26272509 |
Bcl2l11 | Rat | trichostatin A | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of BCL2L11 mRNA | CTD | PMID:24935251 |
Bcl2l11 | Rat | trimellitic anhydride | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of BCL2L11 mRNA | CTD | PMID:19042947 |
Bcl2l11 | Rat | triphenyl phosphate | increases expression | EXP | | 6480464 | triphenyl phosphate results in increased expression of BCL2L11 mRNA | CTD | PMID:30589522 |
Bcl2l11 | Rat | triphenyl phosphate | affects expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of BCL2L11 mRNA | CTD | PMID:37042841 |
Bcl2l11 | Rat | triptonide | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | triptonide results in increased expression of BCL2L11 mRNA | CTD | PMID:33045310 |
Bcl2l11 | Rat | troglitazone | decreases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | troglitazone results in decreased expression of BCL2L11 mRNA | CTD | PMID:28973697 |
Bcl2l11 | Rat | tunicamycin | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | Arsenic Trioxide inhibits the reaction [Tunicamycin results in increased expression of BCL2L11 protein] | CTD | PMID:36509116 |
Bcl2l11 | Rat | tunicamycin | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of BCL2L11 protein | CTD | PMID:36509116 |
Bcl2l11 | Rat | urethane | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Urethane results in increased expression of BCL2L11 mRNA | CTD | PMID:28818685 |
Bcl2l11 | Rat | usnic acid | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | usnic acid results in decreased expression of BCL2L11 mRNA | CTD | PMID:32508146 |
Bcl2l11 | Rat | valproic acid | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of BCL2L11 mRNA | CTD | PMID:32623605 |
Bcl2l11 | Rat | valproic acid | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:32623605 |
Bcl2l11 | Rat | valproic acid | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of BCL2L11 mRNA | CTD | PMID:23179753 more ... |
Bcl2l11 | Rat | valproic acid | affects expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | Valproic Acid affects the expression of BCL2L11 mRNA | CTD | PMID:17963808 |
Bcl2l11 | Rat | valsartan | multiple interactions | EXP | | 6480464 | Valsartan inhibits the reaction [Cyclophosphamide results in increased expression of BCL2L11 mRNA] | CTD | PMID:32197949 |
Bcl2l11 | Rat | vemurafenib | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [BRAF protein mutant form results in increased susceptibility to vemurafenib] which results in increased expression of BCL2L11 protein and [MET protein affects the susceptibility to HGF protein] affects the reaction [[BRAF protein mutant form results in increased susceptibility to vemurafenib] which results in increased expression of BCL2L11 protein] | CTD | PMID:27689874 |
Bcl2l11 | Rat | vorinostat | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:19509267 and PMID:27188386 |
Bcl2l11 | Rat | vorinostat | increases expression | EXP | | 6480464 | Vorinostat results in increased expression of BCL2L11 mRNA and Vorinostat results in increased expression of BCL2L11 protein | CTD | PMID:17331788 |
Bcl2l11 | Rat | vorinostat | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | vorinostat results in increased expression of BCL2L11 mRNA more ... | CTD | PMID:16144943 more ... |
Bcl2l11 | Rat | withaferin A | decreases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | withaferin A results in decreased expression of BCL2L11 protein | CTD | PMID:20438634 |
Bcl2l11 | Rat | withaferin A | multiple interactions | EXP | | 6480464 | withaferin A inhibits the reaction [Cholesterol and Dietary results in increased expression of BCL2L11 protein] | CTD | PMID:35734936 |
Bcl2l11 | Rat | xanthohumol | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | xanthohumol results in increased expression of BCL2L11 alternative form | CTD | PMID:35229981 |
Bcl2l11 | Rat | zinc atom | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Zinc results in increased expression of BCL2L11 mRNA | CTD | PMID:19071009 |
Bcl2l11 | Rat | zinc protoporphyrin | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | zinc protoporphyrin results in increased expression of BCL2L11 protein | CTD | PMID:27829220 |
Bcl2l11 | Rat | zinc(0) | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | Zinc results in increased expression of BCL2L11 mRNA | CTD | PMID:19071009 |
Bcl2l11 | Rat | zoledronic acid | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | [zoledronic acid co-treated with fluvastatin] results in increased expression of BCL2L11 mRNA | CTD | PMID:16996129 |